To transplant only those pulmonary grafts from non-heart-beating donors with excellent function, the authors assessed lungs ex vivo after 4 hours of preservation inside the cadaver, including 90 minutes of warm ischemia and 150 minutes of intrapleural cooling. Graft viability did not deteriorate after additional cold storage up to 24 hours.
The transduction efficiency of an integrin-retargeted adenoviral vector was analyzed in established cell lines, primary cultured human esophageal carcinoma cells, and normal squamous epithelial cells. It was demonstrated that this retargeted virus infects esophageal carcinoma cells more efficiently and more specifically when compared to the parental virus. 
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A Prospective Randomized Study in 100 Consecutive Patients Undergoing Major Liver Resection With Versus Without Ischemic Preconditioning
Pierre-Alain Clavien, MD, PhD, Markus Selzner, MD, Hannes A. Rüdiger, MD, Rolf Graf, PhD, Zakiyah Kadry, MD, Valentin Rousson, PhD, and Wolfram Jochum, MD Ischemic preconditioning has been shown in various animal models and in a pilot study in humans to confer protection against ischemic injury to the liver. We conducted a prospective randomized trial in 100 consecutive unselected patients to establish the protective effects of ischemic preconditioning and showed maximal effects in young patients and patients with steatosis. 
Determinants of Hospital Mortality of Adult Recipients of Right Lobe Live Donor Liver Transplantation
Sheung-Tat Fan, MS, MD, PhD, FRCS, FACS, Chung-Mau Lo, MS, FRCS, FRACS, FACS, Chi-Leung Liu, MS, FRCS, FACS, Boon-Hun Yong, MBBS, FRCP, FANZCA, and John Wong, PhD, FRACS, FRCS, FACS
In a consecutive series of 100 right lobe live donor liver transplantation, there were 8 hospital deaths. Lack of a patent middle hepatic vein, graft size of Յ35% of the estimated standard liver weight, and hypothermia during surgery were identified by multivariate analysis as determinants of hospital mortality.
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Liver Resection for Colorectal Metastases: The Third Hepatectomy
René Adam MD, PhD, Gérard Pascal, MD, Daniel Azoulay, MD, PhD, Kuniya Tanaka, MD, Denis Castaing, MD, and Henri Bismuth, MD, FACS Hon This study analyses the risk, the benefit, and the prognostic factors of the outcome of 60 patients submitted to a third liver resection for colorectal metastases at a single institution. Third hepatectomy is safe and provides when potentially curative, a chance of survival similar to that of first and second liver resections.
Resection Prior to Liver Transplantation for Hepatocellular Carcinoma
Jacques Belghiti, MD, Alexandre Cortes, MD, Eddie K. Abdalla, MD, Jean-Marc Régimbeau, MD, Kurumboor Prakash, MD, François Durand, MD, Daniele Sommacale, MD, Federica Dondero, MD, Mickael Lesurtel, MD, Alain Sauvanet, MD, Olivier Farges, MD, PhD, and Reza Kianmanesh, MD This randomized trial evaluates the role of prophylactic gastrojejunostomy for unresectable periampullary cancer found during laparotomy. Performance of a gastrojejunostomy significantly decreased the incidence of gastric outlet obstruction and the need for reoperation without increasing complication rates. Quality of life was not different in both groups. In unresectable periampullary carcinoma, a combination of a hepaticojejunostomy and a gastrojejunostomy is preferable to a hepaticojejunostomy only. • Volume 238, Number 6, December 2003 Contents (continued) 
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